STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
H
Recruiting
- Leukemia, Myeloid
- Demonstration of T cell responses
- Pierre-Bénite, FranceHôpital Lyon Sud
2021-07-26
Jul 26, 2021A
Not yet recruiting
- Chronic Myeloid Leukemia, Chronic Phase
- +3 more
- Asciminib
- Ascimininb + Nilotinib
- Augusta, GeorgiaGeorgia Cancer Center at Augusta University
2021-11-23
Nov 23, 2021G
Recruiting
- Chronic Myeloid Leukaemia Recurrent
- Chronic Myeloid Leukemia, in Relapse
- Myeloid mutations measurement
- Huixquilucan, Estado De México, MexicoGrupo Cooperativo de Hemopatías Malignas
2021-10-04
Oct 4, 2021N
Recruiting
- Acute Myeloid Leukemia
- Taipei, TaiwanNational Taiwan University Hospital
2021-10-27
Oct 27, 2021E
Not yet recruiting
- Chronic Myeloid Leukemia
- (no location specified)
2022-03-30
Mar 30, 2022C
Recruiting
- Leukemia
- +2 more
- CD123 CAR-T cells
- Chongqing, Chongqing, ChinaChongqing University Cancer Hospital
2021-03-01
Mar 1, 2021C
Recruiting
- Leukemia
- +2 more
- CD123 CAR-T cells
- Kunming, Yunnan, China920th Hospital of Joint Logistics Support Force
2021-03-01
Mar 1, 2021T
Completed
- Acute Myeloid Leukemia, Relapsed, Adult
- CDIAG regimen
- Suzhou, Jiangsu, ChinaThe First Affliated Hospital of Soochow University
2022-03-16
Mar 16, 2022U
Active, not recruiting
- Acute Myeloid Leukemia
- Behavioral: UR-GOAL communication tool
- Rochester, New YorkUniversity of Rochester Medical Center
2022-03-15
Mar 15, 2022U
Active, not recruiting
- Acute Myeloid Leukemia, in Relapse
- +2 more
- CART123 cells; cyclophosphamide; fludarabine
- Philadelphia, PennsylvaniaUniversity of Pennsylvania
2022-01-11
Jan 11, 2022U
Recruiting
- Acute Myeloid Leukemia, in Relapse
- +2 more
- CART123 cells; cyclophosphamide; fludarabine
- Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
2022-02-28
Feb 28, 2022R
Recruiting
- Acute Myeloid Leukemia Refractory
- Acute Myeloid Leukemia, Relapsed, Adult
- UCB-NK cells
- IL-2
- Nijmegen, NetherlandsRadboud University Medical Center
2021-11-10
Nov 10, 2021S
Recruiting
- Myeloid Leukemia, Acute
- +3 more
- Bendamustine Hydrochloride
- Cyclophosphamid
- Saint Petersburg, Russian FederationRM Gorbacheva Research Institute
2022-04-04
Apr 4, 2022M
Available
- Acute Myeloid Leukemia
- +2 more
- flotetuzumab
- (no location specified)
2021-08-18
Aug 18, 2021H
Recruiting
- Acute Myeloid Leukemia
- Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
2021-12-22
Dec 22, 2021N
Not yet recruiting
- Myelodysplastic Syndrome
- +4 more
- UAE Inhibitor TAK-243
- (no location specified)
2022-03-25
Mar 25, 2022U
Recruiting
- Acute Myeloid Leukemia
- Aurora, ColoradoUniverstiy of Colorado Hospital
2022-02-15
Feb 15, 2022M
Recruiting
- Acute Myeloid Leukemia
- +2 more
- Daratumumab/rHuPH20
- +3 more
- Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
2021-11-03
Nov 3, 2021A
Not yet recruiting
- Acute Myeloid Leukemia Refractory
- +2 more
- Marseille, FranceInstitut Paoli Calmettes
2022-01-27
Jan 27, 2022U
Recruiting
- Acute Myeloid Leukemia
- +2 more
- Aurora, Colorado
- +1 more
2021-08-30
Aug 30, 2021P
Recruiting
- CAR
- Acute Myeloid Leukemia
- TAA05 cell injection
- Hefei, Anhui, ChinaAnhui Provincial Hospital
2021-11-03
Nov 3, 2021U
Suspended
- Acute Myeloid Leukemia
- Integrative Therapy
- Gainesville, FloridaUniversity of Florida
2022-01-14
Jan 14, 2022M
Recruiting
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +6 more
- Decitabine
- +2 more
- Houston, TexasM D Anderson Cancer Center
2022-02-25
Feb 25, 2022G
Recruiting
- Acute Myeloid Leukemia
- NanJing, ChinaDepartment of Hematology, Zhongda Hospital, Medical School of So
2022-03-22
Mar 22, 2022K
Not yet recruiting
- Myelofibrosis
- +2 more
- Charlottesville, VirginiaDanyelle Coley
2022-01-31
Jan 31, 2022